You’re offline. This is a read only version of the page.
Toggle navigation
Home
Forums
Products
Sign in
Home
IRIS Stakeholder Forums
What's New in IRIS
IRIS release information - Week of 23 November (R2.2)
IRIS release information - Week of 23 November (R2.2)
Posted
Tue, 24 Nov 2020 09:49:50 GMT
by
Paolo Tomasi
EMA
New process type: “Transfer Scientific Advice”.
Owners of Scientific Advice Regulatory Entitlements (Letters of Advice) are now able to transfer them automatically to another owner, similarly to the RPI transfer process. Only scientific advice entitlements can be transferred with this new automated process, which is necessary when the applicant for a follow-up scientific advice or protocol assistance is not the same of the initial advice. No fee is charged.
New process type:
“
Reassignment of notices for parallel distribution
”. This new type of bulk change procedure is now available for Parallel Distribution. The procedure allows reassigning all notices for parallel distribution held by an applicant to a new owner, where as a result of a merger/acquisition the parallel distributor is dissolved, or the legal form has changed. Applicants are invited to consult the updated
FAQ
and
User guide for Parallel Distribution
for more information.
Applicants have to add at least one
therapeutic area
(top level MedDRA term / SOC) when requesting a new RPI.
The Regulatory Entitlements section in the Industry portal now shows the
Entitlement Status
(active, expired, withdrawn, etc.)
You must be signed in to post in this forum.